Detalles de la búsqueda
1.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(8): 995-1008, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35798016
2.
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.
BMC Cancer
; 20(1): 135, 2020 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32075608
3.
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
Lancet Oncol
; 19(7): 940-952, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29875066
4.
Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using 166Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imaging.
EJNMMI Phys
; 11(1): 33, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38564100
5.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
Lancet Gastroenterol Hepatol
; 9(4): 310-322, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38364832
6.
Transarterial Chemoembolization with Anthracyclines-Loaded Polyethylene Glycol Drug Eluting Microspheres for the Treatment of Hepatocellular Carcinoma: A Pooled Multicentric Analysis of Survival in 580 Patients.
Cardiovasc Intervent Radiol
; 46(4): 436-446, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36764953
7.
Primary extrarenal rhabdoid tumour of the liver: a case report and literature review.
Acta Gastroenterol Belg
; 86(4): 555-562, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240550
8.
Clinical impact of 99mTc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients.
Eur J Hybrid Imaging
; 7(1): 12, 2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414964
9.
Duodenal Hemorrhage Due to an Invasive Hepatocellular Carcinoma Controlled by Transarterial Embolization.
Cureus
; 14(11): e32046, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36600825
10.
Comparison of PMT-based TF64 and SiPM-based Vereos PET/CT systems for 90 Y imaging and dosimetry optimization: A quantitative study.
Med Phys
; 49(12): 7567-7582, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35894818
11.
Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma.
World J Hepatol
; 14(8): 1608-1620, 2022 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36157862
12.
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
Eur J Cancer
; 167: 1-12, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35364421
13.
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.
Clin Cancer Res
; 28(12): 2547-2554, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35421228
14.
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.
Liver Cancer
; 11(5): 460-473, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36158591
15.
In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?
Cancers (Basel)
; 13(20)2021 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34680278
16.
Unusual metastasis in BRCA mutated pancreatic cancer while on maintenance Olaparib: Two case reports and review of the literature.
Eur J Cancer
; 157: 63-67, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34487986
17.
Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis.
Cardiovasc Intervent Radiol
; 44(7): 1048-1059, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709273
18.
Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching.
Liver Cancer
; 10(5): 522-534, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34721513
19.
Balloon-occluded chemoembolization for hepatocellular carcinoma: a prospective study of safety, feasibility and outcomes.
Hepat Oncol
; 8(1): HEP31, 2020 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33680430
20.
Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry.
Cancers (Basel)
; 12(11)2020 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33212917